Drug Trial Radar · NCT05744687
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Last checked: Nov 19, 2026Latest source record: Aug 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
374
Planned (sponsor's estimate)
Start
Apr 24, 2023
Primary completion
May 31, 2026
Study completion May 31, 2026
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Feb 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the safety and efficacy of SPH4336 combined with letrozole in first-line treatment of locally advanced or metastatic breast cancer
Conditions
- Locally Advanced or Metastatic Breast Cancer
Interventions
SPH4336 Tablets 400mgDrug
SPH4336 Tablets :Orally, 400mg once a day; 28 days/cycle Letrozole tablets :Orally, 2.5mg once a day; 28 days/cycle
SPH4336 Tablets PlaceboDrug
SPH4336 Tablets Placebo:Orally,28 days/cycle Letrozole tablets :Orally, 2.5mg once a day; 28 days/cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- response rate (ORR)Time frame: Approximately 3years
- Progression-free survival (PFS)Time frame: Approximately 3years
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Peking University Cancer Hospital
Beijing, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Affiliated Cancer Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, China · Recruiting
AnYang Tumor Hospital
Anyang, Henan, China · Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Recruiting
Pingxiang People's Hospital
Pingxiang, Jiangxi, China · Recruiting
The Second Norman Bethune Hospital of Jilin Univer
Changchun, Jilin, China · Recruiting
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.